News Fire1’s $25m round heads up latest digital health financings There is also new cash for Maribel, HelloSelf, and AI drug discovery firms Protai and Iktos.
News UK MHRA green lights AbbVie’s ELAHERE for ovarian cancer AbbVie has secured UK marketing authorisation for ELAHERE (mirvetuximab soravtansine), the first antibo
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
